• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

Femtech Investment Round-up (February 2024)

By Femtech Insider Investment, Investment Round-ups, News March 4, 2024
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

Career, News, Uncategorized, Women's Health August 10, 2021
Women’s Health Company TherapeuticsMD Announces the Appointment of Hugh O’Dowd as President
Fertility, Investment, Pregnancy, Uncategorized April 5, 2021
Cleo Raises a $40M Series C to Fuel Growth & Launch New Products for Working Families and Their Employers
Recent Posts
  • Seven Starling Raises $8M to Expand Women’s Mental Health Platform in the US
  • Parento Raises $5.9M Seed II to Expand Paid Parental Leave Insurance for Small Businesses
  • What’s New in Femtech This Week? (Sep 18, 2025)
  • Evela Health Completes €2M Funding Round to Transform Menopause Care in German-Speaking Markets
  • Medicines360 Acquires Global Rights to PeriPeach Device for Preventing Severe Perineal Tears

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2025. All rights reserved.